SG11201703415QA - PROPHYLACTIC OR THERAPEUTIC AGENT FOR PEPTIC ULCER, FOOD ADDITIVE FOR PROPHYLACTIC OR THERAPEUTIC USE, iNOS EXPRESSION INHIBITOR AND COX-2 EXPRESSION INHIBITOR - Google Patents

PROPHYLACTIC OR THERAPEUTIC AGENT FOR PEPTIC ULCER, FOOD ADDITIVE FOR PROPHYLACTIC OR THERAPEUTIC USE, iNOS EXPRESSION INHIBITOR AND COX-2 EXPRESSION INHIBITOR

Info

Publication number
SG11201703415QA
SG11201703415QA SG11201703415QA SG11201703415QA SG11201703415QA SG 11201703415Q A SG11201703415Q A SG 11201703415QA SG 11201703415Q A SG11201703415Q A SG 11201703415QA SG 11201703415Q A SG11201703415Q A SG 11201703415QA SG 11201703415Q A SG11201703415Q A SG 11201703415QA
Authority
SG
Singapore
Prior art keywords
prophylactic
expression inhibitor
cox
food additive
peptic ulcer
Prior art date
Application number
SG11201703415QA
Inventor
Eriko Yoshida
Yuta Asayama
Osamu Iwata
Ayaka Nakashima
Kengo Suzuki
Misa Ohgushi
Naoki Harada
Yoshihisa Nakano
Original Assignee
Euglena Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euglena Co Ltd filed Critical Euglena Co Ltd
Priority claimed from PCT/JP2015/081378 external-priority patent/WO2016072507A1/en
Publication of SG11201703415QA publication Critical patent/SG11201703415QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/68—Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SG11201703415QA 2014-11-07 2015-11-06 PROPHYLACTIC OR THERAPEUTIC AGENT FOR PEPTIC ULCER, FOOD ADDITIVE FOR PROPHYLACTIC OR THERAPEUTIC USE, iNOS EXPRESSION INHIBITOR AND COX-2 EXPRESSION INHIBITOR SG11201703415QA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014227305 2014-11-07
JP2015079534A JP6476043B2 (en) 2014-11-07 2015-04-08 Preventive or therapeutic agent for peptic ulcer, and food additive for prevention or treatment
PCT/JP2015/081378 WO2016072507A1 (en) 2014-11-07 2015-11-06 PROPHYLACTIC OR THERAPEUTIC AGENT FOR PEPTIC ULCER, FOOD ADDITIVE FOR PROPHYLACTIC OR THERAPEUTIC USE, iNOS EXPRESSION INHIBITOR AND COX-2 EXPRESSION INHIBITOR

Publications (1)

Publication Number Publication Date
SG11201703415QA true SG11201703415QA (en) 2017-05-30

Family

ID=56071221

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201703415QA SG11201703415QA (en) 2014-11-07 2015-11-06 PROPHYLACTIC OR THERAPEUTIC AGENT FOR PEPTIC ULCER, FOOD ADDITIVE FOR PROPHYLACTIC OR THERAPEUTIC USE, iNOS EXPRESSION INHIBITOR AND COX-2 EXPRESSION INHIBITOR

Country Status (4)

Country Link
US (1) US10117901B2 (en)
JP (1) JP6476043B2 (en)
CN (1) CN107405367A (en)
SG (1) SG11201703415QA (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190054127A1 (en) * 2016-03-04 2019-02-21 Euglena Co., Ltd. Antiviral agent and antiviral food

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084386A (en) * 1989-03-31 1992-01-28 Sri International Production of beta-1,3-glucan in euglena
JP2903318B2 (en) * 1989-04-04 1999-06-07 日研フード株式会社 Antioxidant stress substance
JP2014027929A (en) * 2012-07-06 2014-02-13 Euglena Co Ltd Biological feed additive
JP2014098095A (en) * 2012-11-14 2014-05-29 National Institute Of Advanced Industrial & Technology β-1,3-GLUCAN DERIVATIVE AND MANUFACTURING METHOD OF β-1,3-GLUCAN DERIVATIVE
JP2014118374A (en) * 2012-12-14 2014-06-30 Euglena Co Ltd Diabetes inhibitor
MY173162A (en) 2014-04-08 2019-12-31 Euglena Co Ltd Immune balance regulator

Also Published As

Publication number Publication date
US10117901B2 (en) 2018-11-06
JP2016094381A (en) 2016-05-26
US20170319632A1 (en) 2017-11-09
JP6476043B2 (en) 2019-02-27
CN107405367A (en) 2017-11-28

Similar Documents

Publication Publication Date Title
HK1231513A1 (en) Activin inhibitor response prediction and uses for treatment
AU2015342774B2 (en) EZH2 inhibitors and uses thereof
EP3193608A4 (en) Carm1 inhibitors and uses thereof
EP3151797A4 (en) Methods and devices for treating the skin
EP3157338A4 (en) Inoculants and methods for use thereof
EP3151438A4 (en) Interference cancellation device and method
EP3139556A4 (en) Interference cancellation device and method
EP3151495A4 (en) Interference cancellation device and method
EP3218005A4 (en) Glycan-interacting compounds and methods of use
EP3154972A4 (en) Azamophinan derivatives and use thereof
EP3190970A4 (en) Device and method for detection of haemoglobin and its complexes
PT3543240T (en) Urat1 inhibitor and use thereof
EP3231451A4 (en) Sanitary product and agent for treating sanitary product
EP3215157B8 (en) Apilimod for use in the treatment of melanoma
EP3163932A4 (en) Interference coordination method and device
ZA201701066B (en) Pyridine derivatives and anti-mycobacterial use thereof
EP3122521A4 (en) Leg augmentation systems and methods for use
EP3194377A4 (en) Heterocycle substituted amino-pyridine compounds and methods of use thereof
SG11201605915WA (en) Furo-3-carboxamide derivatives and methods of use
HK1250028A1 (en) 2-phenyl-6-imidazolyl-pyridine-4-carboxamide derivatives and their use as eaat3 inhibitors
EP3124466A4 (en) Triarylamine derivative and use of same
EP3167883A4 (en) PPARy ACTIVATING AGENT
PL3052571T3 (en) Temperature-resistant formulation containing natural coloring agent for food
EP3163945A4 (en) Interference cancellation method and device
SG11201703415QA (en) PROPHYLACTIC OR THERAPEUTIC AGENT FOR PEPTIC ULCER, FOOD ADDITIVE FOR PROPHYLACTIC OR THERAPEUTIC USE, iNOS EXPRESSION INHIBITOR AND COX-2 EXPRESSION INHIBITOR